We recently published 10 Stocks With Easy 15-30% Upside. Avidity Biosciences, Inc. (NASDAQ:RNA) is one of the best-performing ...

In statements to the USA TODAY Network, both the University of Rochester Medical Center, or URMC, and Regeneron noted they ...

Strand Therapeutics has raised $153 million in second-round financing that will be used to move its programmable mRNA ...

Robert F. Kennedy Jr. has launched yet another scientifically unjustified attack on promising vaccine research.

The decision to cancel almost $500 million dollars in U.S. funding for the development of messenger RNA vaccines is dangerous ...

The government’s cancellation of almost $500 million in contracts involving mRNA vaccines could halt progress on cancer ...

When Tiba Biotech was included in the cancelation of $500 million worth grants funding mRNA vaccine development, the company ...

To our immune system, naked RNA is a sign of a viral or bacterial invasion and must be attacked. But our own cells also have RNA.

In a discovery that could broaden access to next-generation biologic medicines and vaccines, researchers at the University of ...

In justifying the government's termination of $500 million in funding for mRNA vaccine projects, Health and Human Services ...

Cells have evolved ingenious ways to defend themselves from viral attack. Research from The Wertheim UF Scripps Institute ...

Jerome Adams, the U.S. Surgeon General under President Trump's first term, is criticizing his administration's cuts to mRNA vaccine research.